Summary
Recently, many surface proteins of lymphoid cells that mediate adhesion to other cells and extracellular matrix have been identified. Several of these cellular adhesion molecules (CAM) are also expressed by metastatic lymphoma cells and may mediate adhesion to tissue components during the metastatic process. Correlations observed between expression of certain CAM, like MEL-14 and CD44, and particular patterns of spread, support this notion, but conclusive evidence is scarce.
We have used T-cell hybridomas to study the mechanisms of wide-spread lymphoid metastasis. The results obtained with this model are reviewed here. The advantages are that a large number of genetically similar cell lines can be generated, which can be grouped in large panels of highly invasive and non-invasive cells. Invasiveness of these cells in hepatocyte and fibroblast monolayers correlates with exprimental metastasis.
Lymphoid CAM that are potentially involved in metastasis are reviewed. Several of these CAM are not, or not consistently, expressed by the invasive T-cell hybridomas, indicating that they are not indispensable. Notably, some of the CAM involved in the onset of an immune response or in migration into inflamed tissues, like ICAM-1 and VLA-4, and the ‘homing receptors’ MEL-14 and LPAM-1 do not seem to be involved. CAM that are consistently expressed by the T-cell hybrids include LFA-1, the beta-1 integrin subunit CD29, CD31 (PECAM-1) and CD44 (‘Hermes homing receptor’).
We have generated considerable evidence that LFA-1 is required for efficient metastasis of T-cell hybrids, based on the behavior of LFA-1-deficient mutants and revertants. High levels of LFA-1 are required. The relevant counterstructure is probably ICAM-2 rather than ICAM-1. Preliminary results suggest that also a beta-1 integrin, possibly VLA-5, plays a role. Finally, we summarize evidence indicating that CD31 and CD44 are primary candidates for involvement in metastatic spread of T-cell hybridomas.
Similar content being viewed by others
References
Dingemans, KP: Behaviour of intravenously injected malignant lymphoma cells. A morphological study. J Natl Cancer Inst 51: 1883–1895, 1973
Roos, E, Dingemans, KP, Van de Pavert, IV, Van den Bergh-Weerman, MA: Invasion of lymphosarcoma cells into the perfused mouse liver. J Natl Cancer Inst 58: 399–407, 1977
La Rivière, G, Schipper, C, Collard, JG, Roos, E: Invasiveness in hepatocyte and fibroblast monolayers and metastatic potential of T-cell hybridomas in mice. Cancer Res 48: 3405–3410, 1988
Bross, ID, Viadana, E, Pickren, JW: The metastatic spread of myeloma and leukemias in men. Virchows Arch (Pathol Anat) 365: 91–101, 1975
De Baetselier, P, Gorelik, E, Eshhar, Z, Ron, Y, Feldman, M, Segal, S: Metastatic properties conferred on non-metastatic tumors by hybridization of spleen B-lymphocytes with plasmacytoma cells. J Natl Cancer Inst 67: 1079–1087, 1981
Brunson, KW, Nicolson, GL: Selection and biologic properties of malignant variants of a murine lymphosarcoma. J Natl Cancer Inst 61: 1499–1503, 1978
Talmadge, JE, Key, ME, Hart, IR: Characterization of a murine ovarian reticulum cell sarcoma of histiocytic origin. Cancer Res 41: 1281–1287, 1981
Roos, E, La Rivière, G, Collard, JG, Stukart, MJ, De Baetselier, P: Invasiveness of T-cell hybridomas in vitro and their metastatic potential in vivo. Cancer Res 45: 6238–6243, 1985
De Baetselier, P, Roos, E, Brys, L, Remels, L, Feldman, M: Generation of invasive and metastatic variants of a nonmetastatic variants of a non-metastatic T-cell lymphoma by in vivo fusion with normal host cells. Int J Cancer 34: 731–738, 1984
Roos, E, Van de Pavert, IV: Inhibition of lymphoma invasion and liver metastasis formation by pertussis toxin. Cancer Res 47: 5439–5444, 1987
Liotta, LA, Mandler, R, Murano, G, Katz, DA, Gordon, RK, Chiang, PK, Schiffmann, E: Tumor cell autocrine motility factor. Proc Natl Acad Sci USA 83: 3302–3306, 1986
Stryer, L, Bourne, HR: G proteins: a family of signal transducers. Ann Rev Cell Biol 2: 391–419, 1986
Collard, JG, Schijven, JF, Roos, E: Invasive and metastatic potential induced by ras-transfection into mouse BW5147 T-lymphoma cells. Cancer Res 47: 754–759, 1987
Greig, RG, Koestler, TP, Trainer, DL, Corwin, SP, Miles, L, Kline, T, Sweet, R, Yokoyama, S, Poste, G: Tumorigenic and metastatic properties of ‘normal’ and ras-transfected NIH/3T3 cells. Proc Natl Acad Sci USA 82: 3698–3701, 1985
Thorgeirsson, UP, Turpeenniemi-Hujanen, T, Williams, JE, Westin, EH, Heilman, CA, Talmadge, JE, Liotta, LA: NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5: 259–262, 1985
Bondy, GP, Wilson, S, Chambers, AF: Experimental metastatic ability of H-ras transformed NIH 3T3 cells. Cancer Res 45: 6005–6009, 1985
Egan, SE, Wright, JA, Jarolim, L, Yanagihara, K, Bassin, RH, Greenberg, AH: Transformation by oncogenes encoding protein kinases induces the metastatic phenotype. Science 238: 202–205, 1987
Kerbel, RS, Lagarde, EA, Dennis, JW, Donaghue, TP: Spontaneous fusion between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin resistant mutant tumor. Mol Cell Biol 3: 523–538, 1983
Larizza, L, Schirrmacher, V, Graf, L, Pfluger, E, Perez-Martinez, M, Stohr, M: Suggestive evidence that the highly metastatic variant ESb is derived from spontaneous fusion with a host macrophage. Int J Cancer 34: 699–707, 1984
Roos, E, Van de Pavert, IV: Antigen-activated T-lymphocytes infiltrate hepatocyte cultures in a manner comparable to liver-colonizing lymphosarcoma cells. Clin Exp Metastasis 1: 173–180, 1983
Naparstek, Y, Cohen, IR, Fuks, Z, Vlodavsky, I: Activated T-lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature 316: 241–244, 1984
Savion, N, Vlodavski, I, Fuks, Z: Interaction of T-lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion and subsequent degradation of the subendothelial extracellular matrix. J Cell Physiol 118: 169–178, 1984
Harris, H, Miller, OJ, Klein, G, Worst, P, Tachibana, T: Suppression of malignancy by cell fusion. Nature 223: 363–367, 1969
Klinger, HP, Shows, TB: Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells. J Natl Cancer Inst 71: 559–569, 1983
Ramshaw, IA, Carlsen, S, Wang, HC, Badenoch-Jones, P: The use of cell fusion to analyse factors involved in tumour cell metastasis. Int J Cancer 32: 471–478, 1983
Sidebottom, E, Clark, SR: Cell fusion segregates progressive growth from metastasis. Br J Cancer 47: 399–406, 1983
Weinberg, RA: Oncogenes, anti-oncogenes, and the molecular basis of multistep carcinogenesis. Cancer Res 49: 3713–3721, 1989
Collard, JG, Van de Poll, M, Scheffer, A, Roos, E, Hopman, AHM, Geurts Van Kessel, AHM, Van Dongen, JJM: Location of genes involved in invasion and metastasis on human chromosome 7. Cancer Res 47: 6666–6670, 1987
Nicolson, GL, Belloni, PN, Tressler, RJ, Dulski, K, Inoue, T, Cavanaugh, PG: Adhesive, invasive, and growth properties of selected metastatic variants of a murine large-cell lymphoma. Invasion Metastasis 9: 102–116, 1989
Pauli, BU, Lee, CL: Organ preference of metastasis. The role of organ-specifically modulated endothelial cells. Lab Invest 58: 379–387, 1988
Roos, E, Tulp, A, Middelkoop, OP, Van de Pavert, IV: Interactions between lymphoid tumor cells and isolated liver endothelial cells. J Natl Cancer Inst 72: 1173–1180, 1984
Roos, E, Van de Pavert, IV, Middelkoop, OP: Infiltration of tumour cells into cultures of isolated hepatocytes. J Cell Sci 47: 385–397, 1981
Schirrmacher, V, Shant, G, Clauer, K, Komitowski, D, Zimmermann, HP, Lohmann-Mathes, ML: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer 23: 233–244, 1979
Kerbel, RS, Twiddy, RR, Robertson, DM: Induction of a tumor with greatly increased metastatic growth potential by injection of cells from a low-metastatic H-2 heterozygous tumor cell line into an H-2 incompatible parental strain. Int J Cancer 22: 583–594, 1978
Verschueren, H, Dekegel, D, De Baetselier, P: Development of a monolayer invasion assay for the discrimination and isolation of metastatic lymphoma cells. Invasion Metastasis 7: 1–15, 1987
Edelman, GM: Cell adhesion molecules in the regulation of animal form and tissue pattern. Ann Rev Cell Biol 2: 81–116, 1986
Hynes, RO: Integrins: A family of cell surface receptors. Cell 48: 549–554, 1987
Ruoslahti, E, Pierschbacher, MD: New perspectives in cell adhesion: RGD and integrins. Science 238: 491–497, 1987
Sanchez-Madrid, F, Nagy, JA, Robbins, E, Simon, P, Springer, TA: Characterization of a human leucocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: The lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule. J Exp Med 158: 1785–1803, 1983
Springer, TA, Dustin, ML, Kishimoto, TK, Marlin, SD: The Lymphocyte Function-Associated LFA-1, CD2, and LFA-3 molecules: Cell adhesion receptors of the immune system. Ann Rev Immunol 3: 223–252, 1987
Kishimoto, TK, Larson, RS, Corbi, AL, Dustin, ML, Staunton, DE, Springer, TA: The leukocyte integrins. Adv Immunol 46: 149–182, 1989
Anderson, DC, Miller, LJ, Schmalstieg, FC, Rothlein, R, Springer, TA: Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: Structure-function assessments employing subunit-specific monoclonal antibodies. J Immunol 137: 15–27, 1986
Keizer, GD, Te Velde, AA, Schwarting, R, Figdor, CG, De Vries, JE: Role of p150,95 in adhesion, migration, chemotaxis and phagocytosis of human monocytes. Eur J Immunol 17: 1317–1322, 1987
Springer, TA, Thompson, WS, Miller, LJ, Schmalstieg, FC, Anderson, DC: Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis. J Exp Med 160: 1901–1918, 1984
Springer, TA, Miller, LJ, Anderson, DC: p150,95, the third member of the Mac-1, LFA-1 human leukocyte adhesion glycoprotein family. J Immunol 136: 240–245, 1986
Bongrand, P, Pierres, M, Golstein, P: T-cell-mediated cytolysis: on the strength of effector-target cell interaction. Eur J Immunol 13: 424–429, 1983
Davignon, D, Martz, E, Reynolds, T, Kürzinger, K, Springer, TA: Lymphocyte function associated antigen one (LFA-1): a surface antigen distinct from Lyt-2/3 that participates in T-lymphocyte-mediated killing. Proc Natl Acad Sci USA 78: 4535–4539, 1981
Davignon, D, Martz, E, Reynolds, T, Kürzinger, K, Springer, TA: Monoclonal antibody to a novel lymphocyte function-associated antigen (LFA-1). Mechanism of blockade of T-lymphocyte-mediated killing and effects on other T and B lymphocyte functions. J Immunol 127: 590–595, 1981
Miedema, F, Tetteroo, PAT, Hesselink, WG, Spits, H, Melief, CJM: Both Fc receptors and lymphocyte function-associated antigen 1 on human T lymphocytes are required for antibody-dependent cellular cytotoxicity (killer cell activity). Eur J Immunol 14: 518–523, 1984
Rosenstein, M, Yron, I, Kaufmann, Y, Rosenberg, SA: Lymphokine activated killer cells. Lysis of fresh syngeneic natural killer resistant murine tumor cells by lymphocytes cultured in interleukin 2. Cancer Res 44: 1946–1953, 1984
Strassman, G, Springer, TA, Somers, SD, Adams, DO: Mechanisms of tumor cell capture by activated macrophages: evidence for involvement of lymphocyte function-associated (LFA)-1 antigen. J Immunol 136: 4328–4333, 1986
Mentzer, SJ, Burakoff, SJ, Faller, DV: Adhesion of T-lymphocytes to human endothelial cells is regulated by the LFA-1 membrane molecule. J Cell Physiol 126: 285–290, 1986
Van Epps, DE, Potter, J, Vachula, M, Smith, CW, Anderson, DC: Suppression of human lymphocyte chemotaxis and transendothelial migration by anti-LFa-1 antibody. J Immunol 143: 3207–3210, 1989
Roos, E, Roossien, FF: Involvement of leucocyte function associated antigen-1 (LFA-1) in the invasion of hepatocyte cultures by lymphoma and T-cell hybridoma cells. J Cell Biol 105: 553–559, 1987
Roossien, FF, Bikker, A, De Rijk, D, Roos, E: Involvement of LFA-1 in lymphoma invasion and metastasis demonstrated with LFA-1-deficient mutants. J Cell Biol 108: 1979–1985, 1989
Roossien, FF, De Kuiper, PE, De Rijk, D, Roos, E: Invasive and metastatic capacity of revertants of LFA-1-deficient mutant T-cell hybridomas. Cancer Res 50: 3509–3513, 1990
Kishimoto, TK, O'Connor, K, Lee, A, Roberts, TM, Springer, TA: Cloning of the beta subunit of the leukocyte adhesion proteins: homology to an extracellular matrix protein defines a novel supergene family. Cell 48: 681–690, 1987
Larson, RS, Corbi, AL, Berman, L, Springer, TA: Primary structure of the leukocyte function-associated molecule-1 alpha subunit: an integrin with an embedded domain defining a protein superfamily. J Cell Biol 108: 703–712, 1989
Wilson, RW, O'Brien, WE, Beaudet, AL: Nucleotide sequence of the cDNA from the mouse leukocyte adhesion protein CD18. Nucl Acids Res 17: 5397, 1989
Rothlein, R, Dustin, ML, Marlin, SD, Springer, TA: A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 137: 1270–1274, 1986
Dustin, ML, Rothlein, R, Bhan, AK, Dinarello, CA, Springer, TA: Induction by IL 1 and interferon-gamma: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245–255, 1986
Staunton, DE, Marlin, SD, Stratowa, C, Dustin, ML, Springer, TA: Primary structure of ICAM-1 demonstrates interaction between members of the immunoglobulin and integrin supergene families. Cell 52: 925–933, 1988
Staunton, DE, Dustin, ML, Springer, TA: Functional cloning of ICAM-2, a cell adhesion ligand for LFA-1 homologous to ICAM-1. Nature 339: 61–64, 1989
Rothlein, R, Czajkowski, M, O'Neill, MM, Marlin, SD, Mainolfi, E, Merluzzi, VJ: Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. J Immunol 141: 1665–1669, 1988
Dustin, ML, Springer, TA: T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 341: 619–624, 1989
Van Kooyk, Y, Van de Wiel-Van Kemenade, P, Weder, P, Kuijpers, TW, Figdor, CG: Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 342: 811–813, 1989
Larson, RS, Hibbs, ML, Springer, TA: The leukocyte integrin LFA-1 reconstituted by cDNA transfection in a nonhematopoietic cell line is functionally active and not transiently regulated. Cell Regulation 1: 359–367, 1990
Staunton, DE, Dustin, ML, Erickson, HP, Springer, TA: The arrangement of the immunoglobulin-like domains of ICAM-1 and the binding sites for LFA-1. Cell 61: 243–254, 1990
Sanders, ME, Makgoba, MW, Sharrow, SO, Stephany, D, Springer, TA, Young, HA, Shaw, S: Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. J Immunol 140: 1401–1407, 1988
Hemler, ME, Crouse, C, Takada, Y, Sonnenberg, A: Multiple very late antigen (VLA) heterodimers on platelets. Evidence for distinct VLA-2, VLA-5 (fibronectin receptor), and VLA-6 structures. J Biol Chem 263: 7660–7665, 1988
Hemler, MA, Huang, C, Schwarz, L: The VLA protein family. Characterization of five distinct cell surface heterodimers each with a common 130,000 molecular weight beta subunit. J Biol Chem 262: 3300–3309, 1987
Pytela, R, Piersbacher, MD, Ruoslahti, E: Identification and isolation of a 140 kD cell surface glycoprotein with properties expected of a fibronectin receptor. Cell 40: 191–198, 1985
Horwitz, A, Duggan, K, Greggs, R, Decker, C, Buck, C: The cell substrate attachment (CSAT) antigen has properties of a receptor for laminin and fibronectin. J Cell Biol 101: 2134–2144, 1985
Tamkun, JW, DeSimone, DW, Fonda, D, Patel, RS, Buck, C, Horwitz, AF, Hynes, RO: Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin. Cell 46: 271–282, 1986
Tomaselli, KJ, Damsky, CH, Reichardt, LF: Purification and characterization of mammalian integrins expressed by a rat neuronal cell line (PC12): Evidence that they function as alpha/beta heterodimeric receptors for laminin and type IV collagen. J Cell Biol 107: 1241–1252, 1988
Sonnenberg, A, Modderman, PW, Hogervorst, F: Laminin receptor on platelets in the integrin VLA-6. Nature 336: 487–489, 1988
Takada, Y, Hemler, ME: The primary structure of the VLA-2/collagen receptor alpha-2 subunit (platelet GPIa): homology to other integrins and the presence of a possible collagen-binding domain. J Cell Biol 109: 397–407, 1989
Carter, WG, Wayner, EA, Bouchard, TS, Kaur, P: The role of integrins alpha-2/beta-1 and alpha-3/beta-1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 110: 1387–1404, 1990
kaufmann, R, Frosch, D, Westphal, C, Weber, L, Klein, CE: Integrin VLA-3: ultrastructural localization at cell-cell contact sites of human cell cultures. J Cell Biol 109: 1807–1815, 1989
Larjava, H, Peltonen, J, Akiyama, SK, Yamada, SS, Gralnick, HR, Uitto, J, Yamada, KM: Novel function for beta-1 integrins in keratinocyte cell-cell interactions. J Cell Biol 110: 803–815, 1990
Shimizu, Y, Van Seventer, GA, Horgan, KJ, Shaw, S: Regulated expression and binding of three VLA (beta-1) integrin receptors on T cells. Nature 345: 250–253, 1990
Terranova, VP, Liotta, LA, Russo, RG, Martin, GR: role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res 42: 2265–2269, 1982
Iwamoto, Y, Robey, FA, Graf, J, Sasaki, M, Kleinman, HK, Yamada, Y, Martin, GR: YIGSR, a synthetic laminin pentapeptide, inhibits experimental metastasis formation. Science 238: 1132–1134, 1987
McCarthy, JB, Skubitz, APN, Palm, SL, Furcht, LT: Metastasis inhibition of different tumor types by purified laminin fragments and a heparin-binding fragment of fibronectin. J Natl Cancer Inst 86: 108–116, 1988
Gehlsen, KR, Agraves, WS, Pierschbacher, MD, Ruoslahti, E: Inhibition of in vitro tumor cell invasion by Arg-Gly-Asp-containing synthetic peptides. J Cell Biol 106: 925–930, 1988
Dufour, S, Duband, JL, Humphries, MJ, Obara, M, Yamada, KM, Thiery, JP: Attachment, spreading and locomotion of avian neural crest cells are mediated by multiple adhesion sites on fibronectin molecules. EMBO J 7: 2661–2671, 1988
Wayner, EA, Garcia-Pardo, A, Humphries, MJ, McDonald, JE, Carter, WG: Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J Cell Biol 109: 1321–1330, 1989
Guan, JL, Hynes, RO: Lymphoid cells recognize an alternatively spliced segment of fibronectin via the integrin receptor alpha-4/beta-1. Cell 60: 53–61, 1990
Elices, MJ, Osborn, L, Takada, Y, Crouse, C, Luhowskyj, S, Hemler, ME, Lobb, RR: VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60: 577–584, 1990
Holzmann, B, McIntyre, BW, Weissman, IL: Identification of a murine Peyer's patch-specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4a. Cell 56: 37–46, 1989
Robey, E, Axel, R: CD4: collaborator in immune recognition and HIV infection. Cell 60: 697–700, 1990
Doyle, C, Strominger, JL: Interaction between CD4 and class II molecules mediates cell adhesion. Nature 330: 256–259, 1987
Norment, AM, Salter, RD, Parham, P, Engelhard, VH, Littman, DR: Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336: 79–81, 1988
Bierer, BE, Peterson, A, Corga, JC, Herrmann, SH, Burakoff, SJ: Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med 168: 1145–1156, 1988
Newman, PJ, Berndt, MC, Gorski, J, White, GC, Lyman, S, Paddock, C, Muller, WA: PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247: 1219–1222, 1990
Ohto, H, Maeda, H, Shibata, Y, Chen, RF, Ozaki, Y, Higashihara, M, Takeuchi, A, Tohayama, H: A novel differentiation antigen: two monoclonal antibodies define a 120-kd molecule on neutrophils, monocytes, platelets and activated lymphoblasts. Blood 66: 873–881, 1985
Albelda, SM, Oliver, PD, Romer, LH, Buck, CA: Endo-CAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol 110: 1227–1237, 1990
Heimark, RL, Degner, M, Schwartz, SM: Identification of a Ca-dependent cell-cell adhesion molecule in endothelial cells. J Cell Biol 110: 1745–1756, 1990
Van Mourik, JA, Leeksma, OC, Reinders, JH, De Groot, PG, Zandbergen-Spaargaren, J: Vascular endothelial cells synthesize a plasma membrane protein indistinguishable from the platelet membrane protein IIa. J Biol Chem 260: 11300–11306, 1985
Hamann, A, Jablonski-Westrich, D, Scholz, KU, Duijvestijn, A, Butcher, EC, Thiele, HG: Regulation of lymphocyte homing. J Immunol 140: 737–743, 1988
Stoolman, LM: Adhesion molecules controlling lymphocyte migration. Cell 56: 907–910, 1989
Lakey Berg, E, Goldstein, LA, Jutila, MA, Nakache, M, Picker, LJ, Streeter, PR, Wu, NW, Zhou, D, Butcher, EC: Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 108: 5–18, 1989
Gallatin, M, St. John, TP, Siegelman, M, Reichert, R, Butcher, EC, Weissman, IL: Lymphocyte homing receptors. Cell 44: 673–680, 1986
Bargatze, RF, Wu, NW, Weissman, IL, Butcher, EC: High endothelial venule binding as a predictor of the dissemination of passaged murine lymphomas. J Exp Med 166: 1125–1131, 1987
Jung, TM, Gallatin, WM, Weissman, IL, Dailey, MO: Down-regulation of homing receptors after T cell activation. J Immunol 141: 4110–4117, 1988
Kishimoto, TK, Jutila, MA, Lakey Berg, E, Butcher, EC: Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245: 1238–1241, 1989
Jalkanen, S, Bargatze, RF, De los Toyos, J, Butcher, EC: Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85–95 kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal or synovial endothelial cells. J Cell Biol 105: 983–990, 1987
Picker, LJ, DeLos Toyos, J, Telen, MJ, Haynes, F, Butcher, EC: Monoclonal antibodies against the CD44 [In(Lu)-related p80], and Pgp-1 antigens in man recognize the Hermes class of lymphocyte homing receptors. J Immunol 142: 2046–2051, 1989
Lasky, LA, Singer, MS, Yednock, TA, Dowbenko, D, Fennie, C, Rodriguez, H, Nguyen, T, Stachel, S, Rosen, SD: Cloning of a lymphocyte homing receptor reveals a lectin domain. Cell 56: 1045–1055, 1989
Stamenkovic, I, Amiot, M, Pesando, JM, Seed, B: A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 56: 1057–1062, 1989
Goldstein, LA, Zhou, DFH, Picker, LJ, Minty, CN, Bargatze, RF, Ding, JF, Butcher, EC: A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56: 1063–1072, 1989
Streeter, PR, Rouse, BTN, Butcher, EC: Immunohistologic and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 107: 1853–1862, 1988
Gallatin, WM, Wayner, EA, Hoffman, PA, St. John, T, Butcher, EC, Carter, WG: Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci USA 86: 4654–4658, 1989
Shimizu, Y, Van Seventer, GA, Siraganian, R, Wahl, L, Shaw, S: Dual role of the CD44 molecule in T cell adhesion and activation. J Immunol 143: 2457–2463, 1989
Hale, LP, Singer, KH, Haynes, BF: CD44 antibody against In(Lu)-related p80, lymphocyte homing receptor molecule inhibits the binding of human erythrocytes to T cells. J Immunol 143: 3944–3948, 1989
Miyake, K, Medina, KL, Hayashi, SI, Ono, S, Hamaoka, T, Kincade, PW: Monoclonal antibodies to pgp-1/CD44 block lympho-hemopoiesis in long-term bone marrow cultures. J Exp Med 171: 477–488, 1990
Belitsos, PC, Hildreth, JEK, August, JT: Homotypic cell aggregation induced by anti-CD44(Pgp-1) monoclonal antibodies and related to CD44(Pgp-1) expression. J Immunol 144: 1661–1670, 1990
King, PD, Batchelor, AH, Lawlor, P, Katz, DR: The role of CD44, CD45, CD45RO, CD46 and CD55 as potential anti-adhesion molecules involved in the binding of human tonsillar T cells to phorbol 12-myristate 13-acetate-differentiated U-937 cells. Eur J Immunol 20: 363–368, 1990
St. John, T, Meyer, J, Idzerda, R, Gallatin, WM: Expression of CD44 confers a new adhesive phenotype on transfected cells. Cell 60: 45–52, 1990
Kalomiris, EL, Bourguignon, LYW: Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol 106: 319–327, 1988
Lesley, J, Schulte, R, Hyman, R: Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp Cell Res 187: 224–233, 1990
Aruffo, A, Stamenkovic, I, Melnick, M, Underhill, CB, Seed, B: CD44 is the principal cell surface receptor for hyaluronate. Cell 61: 1303–1313, 1990
Turley, EA, Brassel, P, Moore, D: A hyaluronan-binding protein shows a partial and temporally regulated codistribution with actin on locomoting chick heart fibroblasts. Exp Cell Res 187: 243–249, 1990
Pals, ST, Horst, E, Ossekoppele, GJ, Figdor, CG, Scheper, RJ, Meijer, CJLM: Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma. Blood 73: 885–888, 1989
Mackay, CR, Marston, WL, Dudler, L: Naive and memory T cells show distinct pathways of lymphocyte recirculation. J Exp Med 171: 801–817, 1990
Springer, TA: Adhesion receptors of the immune system. Nature 346: 425–434, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Roos, E. Adhesion molecules in lymphoma metastasis. Cancer Metast Rev 10, 33–48 (1991). https://doi.org/10.1007/BF00046842
Issue Date:
DOI: https://doi.org/10.1007/BF00046842